OmniAb (OABI) Debt Ratio (2021 - 2026)
OmniAb (OABI) reported Debt Ratio of 0.0 for Q1 2026, up 195.97% year-over-year from 0.0 in Q1 2025, and down 1.65% quarter-over-quarter from 0.0 in Q4 2025.
OmniAb (OABI) Debt Ratio (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Debt Ratio data on file, last reported at 0.0 in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.0, up 195.97% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0 (up 195.97% YoY), and the FY2025 annual result was 0.0, up 112.71% from the prior year.
- Debt Ratio fell to 0.0 in Q1 2026 per OABI's latest filing, from 0.0 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.01 in Q4 2022 and troughed at 0.0 in Q1 2022.
- A 5-year average of 0.0 and a median of 0.0 in 2024 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2023 and 2024: Debt Ratio jumped 3224.45% in 2023, then slumped 85.97% in 2024.
- A 5-year view of Debt Ratio shows it stood at 0.01 in 2022, then tumbled by 63.63% to 0.0 in 2023, then plunged by 53.03% to 0.0 in 2024, then surged by 112.71% to 0.0 in 2025, then fell by 1.65% to 0.0 in 2026.
- Business Quant data shows OABI's Debt Ratio at 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.01 |
| Jun 30, 2021 | 0.00 |